Septerna snags $150M series B for pipeline of GPCR therapies tackling hard-to-drug targets

0

11.07.2023 00:54

Fiercebiotech.com

Septerna snags $150M series B for pipeline of GPCR therapies tackling hard-to-drug targets gmasson Mon, 07/10/2023 - 17:54

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *